Physician profile
Terisa Thomas
NPI 1336246321
$1,018.73
in general payments reported to CMS, 2019-2025
15 companies · $50.09 in 2025
The $50.09 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $50.84 · 2021: $187 · 2022: $105 · 2023: $129 · 2024: $101 · 2025: $50.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $310.98 | 2019-2023 | Puraply |
| Smith+Nephew, INC. | $108.11 | 2019-2025 | Collagenase Santyl, Regranex |
| Merck Sharp & Dohme LLC | $101.47 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.73 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $84.00 | 2022 | |
| Kci USA, INC. | $68.38 | 2021-2023 | Promogran Prisma, Activ.A.C., Activ.A.C. Ion Progress |
| Lifenet Health | $63.32 | 2023 | |
| Urgo Medical North America, LLC | $42.05 | 2024 | Urgok2 |
| Paratek Pharmaceuticals, INC. | $29.54 | 2024-2025 | Nuzyra |
| Medtronic, INC. | $26.54 | 2024 | Venaseal |
| Abbvie INC. | $24.32 | 2021 | |
| Integra Lifesciences Corporation | $18.64 | 2019 | |
| Hartmann USA, INC. | $17.32 | 2025 | Zetuvit Plus 10x10 P10 |
| Misonix INC | $12.56 | 2020 | |
| Osiris Therapeutics INC. | $11.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terisa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.